HUMANA INC
HUMNYSE · SIC 6324
$400.00
↑ +3.5%Jul 17 close · end-of-day
Price
1Y↑ +79.1%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$48.3B
Enterprise Value
$40.3B
P/E
42.7
P/S
0.4
P/B
2.6
EV/EBITDA
12.9
PEG
—
FCF Yield
2.6%
Dividend Yield
0.9%
Revenue (TTM)
$137.2B
Net Income (TTM)
$1.1B
Free Cash Flow (TTM)
$1.3B
Gross Margin
—
Operating Margin
1.8%
Net Margin
0.8%
ROE
6.1%
ROIC
18.9%
Debt / Equity
0.8
Net Cash
$8.0B
Return 1Y
+81.5%
Company profile
Humana Inc. operates through three segments: Retail, Group and Specialty, and Healthcare Services. As of December 31, 2021, Humana had approximately 17 million members in medical benefit plans.
- CEO
- Bruce D. Broussard
- Sector
- Finance, Insurance, And Real Estate
- Industry
- Insurance
- Employees
- 67,100
- Headquarters
- Kentucky
- Website
- humana.com
Management & directors
- Dintenfass DavidPresident, Enterprise Growth
- Martin AaronPresident, Medicare Advantage
- Mehta JapanChief Information Officer
- Mellet CelesteChief Financial Officer
- O'Hara Michelle A.Chief Human Resources Officer
- Rechtin James A.President & CEO
- Shetty Sanjay KPresident, CenterWell
- Ventura Joseph CChief Legal Officer
- Felter John-Paul W.SVP, Chief Accting Off & Cont.
- Renaudin George IiPresident, Insurance
- Brown Celeste MChief Financial Officer
Roles derived from SEC Form 4 filings.
Earnings
Next earnings · estimated2026-07-29
HUM Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$39.6B↑ +23.5%
Diluted EPS$9.83↓ -4.6%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $77.2B | $83.1B | $92.9B | $106.4B | $117.8B | $129.7B |
| Gross profit | — | — | — | — | — | — |
| Operating income | $5.0B | $3.1B | $3.8B | $4.0B | $2.6B | $2.7B |
| Net income | $3.4B | $2.9B | $2.8B | $2.5B | $1.2B | $1.2B |
| Diluted EPS | $25.31 | $22.67 | $22.08 | $20.00 | $9.98 | $9.84 |
| Operating cash flow | $5.6B | $2.3B | $4.6B | $4.0B | $3.0B | $921.0M |
| Free cash flow | $4.7B | $920.0M | $3.5B | $3.0B | $2.4B | $375.0M |
| Gross margin | — | — | — | — | — | — |
| Operating margin | 6.5% | 3.8% | 4.1% | 3.8% | 2.2% | 2.1% |
| Net margin | 4.4% | 3.5% | 3.0% | 2.3% | 1.0% | 0.9% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $29.5B | $29.4B | $29.2B | $32.1B | $32.4B | $32.6B | $32.5B | $39.6B |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $1.1B | $728.0M | -$543.0M | $2.0B | $1.1B | $400.0M | -$808.0M | $1.8B |
| Net income | $679.0M | $480.0M | -$693.0M | $1.2B | $545.0M | $195.0M | -$796.0M | $1.2B |
| Diluted EPS | $5.62 | $3.98 | -$5.73 | $10.30 | $4.51 | $1.62 | -$6.59 | $9.83 |
| Operating cash flow | $1.2B | $1.9B | -$528.0M | $331.0M | $1.3B | $971.0M | -$1.7B | $1.3B |
| Free cash flow | $1.1B | $1.7B | -$682.0M | $236.0M | $1.2B | $836.0M | -$1.9B | $1.1B |
| Gross margin | — | — | — | — | — | — | — | — |
| Operating margin | 3.9% | 2.5% | -1.9% | 6.3% | 3.4% | 1.2% | -2.5% | 4.4% |
| Net margin | 2.3% | 1.6% | -2.4% | 3.9% | 1.7% | 0.6% | -2.4% | 3.0% |
Company news
Jul 17, 2026
Jul 16, 2026
- 3d agoUnitedHealth Jumps 10.3% After Raising 2026 EPS Outlook Above Estimatesfinance.yahoo.com
- 4d agoWhy UNH Stock Breakout Faltered After Massive Earnings Beatfinance.yahoo.com
- 4d agoCan Humana (HUM) Run Higher on Rising Earnings Estimates?finance.yahoo.com
- 4d agoInside the UnitedHealth Earnings Beat That Lifted Healthcare Stocksfinance.yahoo.com
- 4d agoUnitedHealth stock jumps on Q2 earnings, raises full-year outlookfinance.yahoo.com
- 4d agoSandisk, Micron, TSMC, UnitedHealth, and More Stocks That Explain Today’s Marketfinance.yahoo.com
- 4d agoThe Medicaid Problem That Swallowed an Earnings Beattrefis.com
- 4d agoThe Medicaid Problem Weighing On Elevance Health Stocktrefis.com
- 4d agoThe Real Price of Admission for CVS Health Stocktrefis.com
- 4d agoSandisk, UnitedHealth, J.B. Hunt, TSMC, and More Stocks That Explain Today’s Marketfinance.yahoo.com
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-05-01 | Mellet Celeste· Chief Financial Officer | Award | 15,387 | $0.00 | $0.00 | filing |
| 2026-05-01 | Dintenfass David· President, Enterprise Growth | Award | 11,273 | $0.00 | $0.00 | filing |
| 2026-05-01 | Field Robert Stuart | Award | 852 | $0.00 | $0.00 | filing |
| 2026-05-01 | Ventura Joseph C· Chief Legal Officer | Award | 10,318 | $0.00 | $0.00 | filing |
| 2026-05-01 | Shetty Sanjay K· President, CenterWell | Award | 9,945 | $0.00 | $0.00 | filing |
| 2026-05-01 | Martin Aaron· President, Medicare Advantage | Award | 8,206 | $0.00 | $0.00 | filing |
| 2026-05-01 | Mehta Japan· Chief Information Officer | Award | 9,448 | $0.00 | $0.00 | filing |
| 2026-05-01 | Rechtin James A.· President & CEO | Award | 35,633 | $0.00 | $0.00 | filing |
| 2026-05-01 | O'Hara Michelle A.· Chief Human Resources Officer | Award | 10,485 | $0.00 | $0.00 | filing |
| 2026-04-01 | Shetty Sanjay K· President, CenterWell | Tax withholding | 401 | $175.44 | $70,351.44 | filing |
| 2026-04-01 | Shetty Sanjay K· President, CenterWell | Option exercise | 887 | $0.00 | $0.00 | filing |
| 2026-02-24 | Ventura Joseph C· Chief Legal Officer | Tax withholding | 478 | $177.08 | $84,641.85 | filing |
| 2026-02-24 | Renaudin George II· President, Insurance | Tax withholding | 419 | $177.08 | $74,194.43 | filing |
| 2026-02-24 | Felter John-Paul W.· SVP, Chief Accting Off & Cont. | Tax withholding | 84 | $177.08 | $14,874.30 | filing |
| 2026-02-24 | Renaudin George II· President, Insurance | Option exercise | 1,035 | $0.00 | $0.00 | filing |
| 2026-02-24 | Ventura Joseph C· Chief Legal Officer | Option exercise | 1,035 | $0.00 | $0.00 | filing |
| 2026-02-24 | Felter John-Paul W.· SVP, Chief Accting Off & Cont. | Option exercise | 165 | $0.00 | $0.00 | filing |
| 2026-02-23 | Shetty Sanjay K· President, CenterWell | Buy | 810 | $185.21 | $150,016.05 | filing |
| 2026-02-23 | Felter John-Paul W.· SVP, Chief Accting Off & Cont. | Award | 5,669 | $0.00 | $0.00 | filing |
| 2026-02-21 | Dintenfass David· President, Enterprise Growth | Tax withholding | 1,182 | $189.66 | $224,172.21 | filing |
| 2026-02-21 | Dintenfass David· President, Enterprise Growth | Option exercise | 3,858 | $0.00 | $0.00 | filing |
| 2026-02-13 | Brown Celeste M· Chief Financial Officer | Tax withholding | 4,204 | $181.46 | $762,847.33 | filing |
| 2026-02-13 | Mehta Japan· Chief Information Officer | Tax withholding | 430 | $181.46 | $78,026.73 | filing |
| 2026-02-13 | Mehta Japan· Chief Information Officer | Option exercise | 1,682 | $0.00 | $0.00 | filing |
| 2026-02-13 | Brown Celeste M· Chief Financial Officer | Option exercise | 7,763 | $0.00 | $0.00 | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.